Sandbox:kalpana: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Historical Perspective | ==Historical Perspective== | ||
==Diagnosis== | ==Diagnosis== | ||
| Line 6: | Line 6: | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
The | The patient with fetal hydantoin syndrome have positive history of exposure to phenytoin during pregnancy. | ||
The risk of neurological impairment estimated to be 1% to 11% is 2 to 3 times higher than in the general population. The risk of oral clefts and cardiac anomalies is 5 times than others in hydantoin exposed infants. Less frequently observed abnormalities include microcephaly, ocular defects, hypospadias, umbilical and inguinal hernias. | |||
==Physical Examination== | |||
Common physical examination findings of fetal hydantoin syndrome includes | |||
*microcephaly, distinctive facial and limb anomalies, ocular defects, growth deficiency, congenital heart defects, cardiac rhythm disturbances, and variable systemic abnormalities involving the nervous, renal, and gastrointestinal systems. | |||
*Congenital heart diseases associated with fetal hydantoin syndrome include pulmonary or aortic valvular stenosis, coarctation of aorta, patent ductus arteriosus, and ventricular septal defects.<ref name="pmid28578158">{{cite journal| author=Hegde A, Kaur A, Sood A, Dhanorkar M, Varma HT, Singh G | display-authors=etal| title=Fetal Hydantoin Syndrome. | journal=J Pediatr | year= 2017 | volume= 188 | issue= | pages= 304 | pmid=28578158 | doi=10.1016/j.jpeds.2017.05.018 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28578158 }} </ref> | |||
Revision as of 09:08, 9 May 2021
Historical Perspective
Diagnosis
Diagnostic Study of Choice
The diagnosis of fetal hydantoin syndrome is based on secondary to in utero phenytoin exposure.
History and Symptoms
The patient with fetal hydantoin syndrome have positive history of exposure to phenytoin during pregnancy. The risk of neurological impairment estimated to be 1% to 11% is 2 to 3 times higher than in the general population. The risk of oral clefts and cardiac anomalies is 5 times than others in hydantoin exposed infants. Less frequently observed abnormalities include microcephaly, ocular defects, hypospadias, umbilical and inguinal hernias.
Physical Examination
Common physical examination findings of fetal hydantoin syndrome includes
- microcephaly, distinctive facial and limb anomalies, ocular defects, growth deficiency, congenital heart defects, cardiac rhythm disturbances, and variable systemic abnormalities involving the nervous, renal, and gastrointestinal systems.
- Congenital heart diseases associated with fetal hydantoin syndrome include pulmonary or aortic valvular stenosis, coarctation of aorta, patent ductus arteriosus, and ventricular septal defects.[1]
- ↑ Hegde A, Kaur A, Sood A, Dhanorkar M, Varma HT, Singh G; et al. (2017). "Fetal Hydantoin Syndrome". J Pediatr. 188: 304. doi:10.1016/j.jpeds.2017.05.018. PMID 28578158.